Development of a Sustained Release Dosage Form for Phenylephrine Hydrochloride using Solid Lipid Pellets
The purpose of this work was to demonstrate proof-of-concept for a stable sustained release dosage form containing phenylephrine hydrochloride (PE HCI) using Capsugel's Solid Lipid Pellets (SLP) technology.